188 related articles for article (PubMed ID: 16266120)
1. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. I. Taxonomy, fermentation, isolation and biological activities.
Furukawa S; Tsurumi Y; Murakami K; Nakanishi T; Ohsumi K; Hashimoto M; Nishikawa M; Takase S; Nakayama O; Hino M
J Antibiot (Tokyo); 2005 Aug; 58(8):497-502. PubMed ID: 16266120
[TBL] [Abstract][Full Text] [Related]
2. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models.
Furukawa S; Murakami K; Nishikawa M; Nakayama O; Hino M
J Antibiot (Tokyo); 2005 Aug; 58(8):503-6. PubMed ID: 16266121
[TBL] [Abstract][Full Text] [Related]
3. Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
Nagy L; Béke F; Juhász L; Kovács T; Juhász-Tóth É; Docsa T; Tóth A; Gergely P; Somsák L; Bai P
PLoS One; 2020; 15(9):e0236081. PubMed ID: 32960890
[TBL] [Abstract][Full Text] [Related]
4. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
Baker DJ; Greenhaff PL; MacInnes A; Timmons JA
Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
[TBL] [Abstract][Full Text] [Related]
5. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Andersen B; Westergaard N
Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM
Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477
[TBL] [Abstract][Full Text] [Related]
7. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
Kristiansen M; Andersen B; Iversen LF; Westergaard N
J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781
[TBL] [Abstract][Full Text] [Related]
8. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
[TBL] [Abstract][Full Text] [Related]
9. FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase.
Tiraidis C; Alexacou KM; Zographos SE; Leonidas DD; Gimisis T; Oikonomakos NG
Protein Sci; 2007 Aug; 16(8):1773-82. PubMed ID: 17600143
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and glycogen phosphorylase inhibitor activity of functionalized 1,4-benzodioxanes.
Czakó Z; Docsa T; Gergely P; Juhász L; Antus S
Pharmazie; 2010 Apr; 65(4):235-8. PubMed ID: 20432616
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and glycogen phosphorylase inhibitor activity of 2,3-dihydrobenzo[1,4]dioxin derivatives.
Juhász L; Docsa T; Brunyászki A; Gergely P; Antus S
Bioorg Med Chem; 2007 Jun; 15(12):4048-56. PubMed ID: 17451960
[TBL] [Abstract][Full Text] [Related]
12. Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.
Zhu P; Bi Y; Xu J; Li Z; Liu J; Zhang L; Ye W; Wu X
Bioorg Med Chem Lett; 2009 Dec; 19(24):6966-9. PubMed ID: 19889536
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
Varga G; Docsa T; Gergely P; Juhász L; Somsák L
Bioorg Med Chem Lett; 2013 Mar; 23(6):1789-92. PubMed ID: 23395662
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site.
Hampson LJ; Arden C; Agius L; Ganotidis M; Kosmopoulou MN; Tiraidis C; Elemes Y; Sakarellos C; Leonidas DD; Oikonomakos NG
Bioorg Med Chem; 2006 Dec; 14(23):7835-45. PubMed ID: 16908161
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
Cheng K; Liu J; Sun H; Xie J
Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
[TBL] [Abstract][Full Text] [Related]
16. Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
Chen J; Liu J; Zhang L; Wu G; Hua W; Wu X; Sun H
Bioorg Med Chem Lett; 2006 Jun; 16(11):2915-9. PubMed ID: 16546381
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a.
Li YH; Coppo FT; Evans KA; Graybill TL; Patel M; Gale J; Li H; Tavares F; Thomson SA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5892-6. PubMed ID: 16942879
[TBL] [Abstract][Full Text] [Related]
18. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
19. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases.
Wen X; Xia J; Cheng K; Zhang L; Zhang P; Liu J; Zhang L; Ni P; Sun H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5777-82. PubMed ID: 17869102
[TBL] [Abstract][Full Text] [Related]
20. Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. I. Taxonomy, fermentation, isolation, and biological activities.
Yano T; Aoyagi A; Kozuma S; Kawamura Y; Tanaka I; Suzuki Y; Takamatsu Y; Takatsu T; Inukai M
J Antibiot (Tokyo); 2007 Feb; 60(2):136-42. PubMed ID: 17420564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
